KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.Nat MedPMID 38191615无 PMCID2024-Jan0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study).JCO Glob OncolPMID 38237092PMC108054402024-Jan0.98未发现恶性肿瘤人群证据。待处理
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial.Lancet RheumatolPMID 38258678无 PMCID2024-Jan0.98未发现恶性肿瘤人群证据。待处理
Comparison of influenza viral load in nasopharyngeal and midturbinate swabs.Influenza Other Respir VirusesPMID 38260724PMC108002932024-Jan0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of lubiprostone for the treatment of chronic idiopathic constipation: A phase 3, randomized, placebo-controlled study.Rev Gastroenterol Mex (Engl Ed)PMID 37225537无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.NephronPMID 37473746PMC1079496520240.98未发现恶性肿瘤人群证据。待处理
Brain Injury Outcomes after Adjuvant Erythropoietin Neuroprotection for Moderate or Severe Neonatal Hypoxic-Ischemic Encephalopathy: A Report from the HEAL Trial.Dev NeurosciPMID 37906983PMC1124906120240.98未发现恶性肿瘤人群证据。待处理
Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study).OncologyPMID 38048759PMC1115202820240.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.DermatologyPMID 38081155PMC1099724520240.98未发现恶性肿瘤人群证据。待处理
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2.Am J NephrolPMID 38253036PMC1115200320240.98未发现恶性肿瘤人群证据。待处理
Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.J Alzheimers DisPMID 38427485PMC1097735120240.98未发现恶性肿瘤人群证据。待处理
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].Zh Nevrol Psikhiatr Im S S KorsakovaPMID 38676683无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Assessment of safety and tolerability of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: Results of an open-label, randomized, multicenter, phase IIIB ESCAPE trial.Cancer Treat Res CommunPMID 38735220无 PMCID20240.95The trial is oncology, human, randomized, Phase IIIB, drug-intervention, and an original result report. However, it lacks a primary or key secondary time-to-event efficacy endpoint as defined (OS, PFS, DFS, EFS, RFS, TTP, Kaplan-Meier, or HR). The results focus on patient preference, administration time, and safety, making it ineligible.待处理
Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3.DermatologyPMID 38934147PMC1165133920240.98未发现恶性肿瘤人群证据。待处理
Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial.J Prev Alzheimers DisPMID 39044494PMC1126625620240.98未发现恶性肿瘤人群证据。待处理
Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease.J Prev Alzheimers DisPMID 39044495PMC1126636620240.98未发现恶性肿瘤人群证据。待处理
Randomized Controlled Trial of Remimazolam Compared with Placebo in Japanese Patients Undergoing Colonoscopy: A Phase III, Investigator-Initiated Trial.DigestionPMID 39068917PMC1163386220240.98未发现恶性肿瘤人群证据。待处理
Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial.Future OncolPMID 39072392PMC1148587820240.98未发现恶性肿瘤人群证据。待处理
Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD).J Alzheimers DisPMID 39177596PMC1138029020240.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of Vero cell culture-derived Japanese encephalitis vaccine: a phase 3 study in Chinese infants.Expert Rev VaccinesPMID 39279603无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial.Cancer Treat Res CommunPMID 39305541无 PMCID20240.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Summary of quality of life in the ASCENT phase 3 clinical trial for people with metastatic triple-negative breast cancer.Future OncolPMID 39324726PMC1153729120240.90The document is an original report from a Phase III randomized trial, but its sole focus is a quality-of-life analysis. It does not contain or report the primary or key secondary time-to-event efficacy endpoints (OS, PFS, DFS, etc.) required for inclusion in this KM digitization cohort.待处理
Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease.J Prev Alzheimers DisPMID 39350371PMC1143640020240.98未发现恶性肿瘤人群证据。待处理
Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050.Future OncolPMID 39360943PMC1157231220240.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II).ImmunotherapyPMID 39781908PMC1175953020240.98未发现恶性肿瘤人群证据。待处理
Effects of MDMA-assisted therapy for PTSD on self-experience.PLoS OnePMID 38198456PMC1078110620240.98未发现恶性肿瘤人群证据。待处理
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.Front ImmunolPMID 38420129PMC1090084320240.98未发现恶性肿瘤人群证据。待处理
Abemaciclib as adjuvant treatment for high-risk early breast cancer.Farm HospPMID 37735004无 PMCID20240.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials.J Clin LipidolPMID 38341323无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19.Front ImmunolPMID 38694503PMC1106148020240.98未发现恶性肿瘤人群证据。待处理
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®.DermatitisPMID 38108653无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis.Pediatr DermatolPMID 38413239无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Association of baseline factors with 1-year outcomes in the SB11-ranibizumab equivalence trial: A post hoc analysis.Asia Pac J Ophthalmol (Phila)PMID 38759795无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study.Indian Heart JPMID 38871219PMC1132906420240.98未发现恶性肿瘤人群证据。待处理
Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: a study based on CGM in type 2 diabetes in China.Front Endocrinol (Lausanne)PMID 38774225PMC1110644720240.98未发现恶性肿瘤人群证据。待处理
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity.Front ImmunolPMID 38827749PMC1114379520240.98未发现恶性肿瘤人群证据。待处理
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study.Front ImmunolPMID 38863717PMC1116514020240.98未发现恶性肿瘤人群证据。待处理
Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial.Front ImmunolPMID 38903523PMC1118730320240.98未发现恶性肿瘤人群证据。待处理
Cardiopulmonary Protection of Modified Remote Ischemic Preconditioning in Mitral Valve Replacement Surgery: A Randomized Controlled Trial.Cardiovasc TherPMID 39742012PMC1122199620240.90The study is a randomized controlled trial in human patients undergoing mitral valve replacement surgery, but it is not an oncology trial. It investigates a non-drug intervention (remote ischemic preconditioning) for cardiopulmonary protection, and its primary endpoint is a biomarker (cardiac troponin I concentration), not a time-to-event efficacy outcome (e.g., OS, PFS, DFS). Therefore, it does not meet the inclusion criteria for the oncology Kaplan-Meier digitization cohort.待处理
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial.Semin Thorac Cardiovasc SurgPMID 36272526无 PMCID20240.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.HeadachePMID 38982666无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients.Indian Heart JPMID 39009075PMC1145135520240.98未发现恶性肿瘤人群证据。待处理
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.PLoS OnePMID 39042627PMC1126572020240.98未发现恶性肿瘤人群证据。待处理
Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors.PLoS OnePMID 39079163PMC1128595120240.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial.Front ImmunolPMID 39136011PMC1131739920240.98未发现恶性肿瘤人群证据。待处理
Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5-11 years: a phase 2/3, randomized, active-controlled study.Front ImmunolPMID 39286253PMC1140324820240.98未发现恶性肿瘤人群证据。待处理
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ-population-based follow-up of two cluster-randomized trials.Front Cell Infect MicrobiolPMID 39315334PMC1141709920240.90The study is an oncology Phase III randomized trial with a drug intervention and original results, but it lacks a primary or key secondary time-to-event efficacy endpoint (e.g., OS, PFS, DFS, EFS, RFS, TTP, Kaplan-Meier, HR). The primary outcome is vaccine efficacy against cervical neoplasia, measured as relative risk reduction or incidence comparison, not survival analysis.待处理
Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial.Acta Gastroenterol BelgPMID 39745035无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes.Pediatr DiabetesPMID 40302969PMC1201677220240.98未发现恶性肿瘤人群证据。待处理
Revefenacin Area Under the Curve Spirometry in Patients with Moderate to Very Severe COPD.Int J Chron Obstruct Pulmon DisPMID 39429809PMC1149109820240.98未发现恶性肿瘤人群证据。待处理